Near future
No Result
View All Result
24 September 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

Molnupiravir, Merck's anti-Covid breakthrough, acts by 'confusing' the virus

It is called Molnupiravir and for days we have been talking about nothing but this antiviral that can help us give a perhaps decisive blow to Covid. But how does it work?

October 5, 2021
Gianluca RiccioGianluca Riccio
⚪ 3 minutes
Share14Pin4Tweet9SendShare3ShareShare2
Molnnupiravir

READ IN:

The latest vessel in the fleet that scientists are fielding to fight COVID-19 is not a new vaccine, we already have a lot of them. It's an antiviral pill: it's called molnupiravir and for days we have talked about nothing else. But how does it work?

Today we announced positive interim data for our investigation # COVID19 #antiviral treatment. Learn more about our latest news: https://t.co/v1DDAa4RjN $ MRK pic.twitter.com/na2O4Y5N3D

- Merck (@Merck) October 1, 2021

Molnupiravir's potential breakthrough was discovered by researchers at Emory University, and companies Merck and Ridgeback Biotherapeutics rushed to license it. After the hype of the announcements, let's take a look. Making an obvious general premise.

Antiviral treatments aim to kill or inhibit the development of viruses and are part of a wider range of antimicrobial treatments. Other types of antivirals include treatments for herpes, HIV, and the common flu. Some other examples of antimicrobial treatments include antibiotic-fought bacteria and antifungal-fought fungi.

Halve hospitalization and death?

According to a press release, the companies said Molnupravir has achieved impressive results. Patients who received a dose of the Merck pill were hospitalized (or died from Covid) to a far lesser extent than those who were given a placebo pill.

The numbers stand at 7,3% of 385 patients who received one dose compared to 14,1% of the 377 who received a placebo. In summary, it's about 50% cheaper. A pill that halves the risks in one fell swoop.

The article continues after the related links

To REALLY avoid new pandemics, the fur industry needs to be wiped out

There is never peace for the WHO chief: prepare for a disease more lethal than COVID

At this time, the only other drug approved by the FDA for the treatment of COVID-19 is remive. The US sent it to China as early as February 2020, when it was still experimental, as a form of aid. However, remdesivir requires a drip in the form of an infusion or injection and is not easy to administer. Molnupiravir no. It can be made into pills.

How does Molnupiravir work? A pharmaceutical "hacker".

Molnupiravir's differences are also in approach. This drug will work differently against the virus. To be simple, it manages to enter the genetic material of the virus and introduces "errors" to essentially confuse the genes. These errors break down its ability to replicate itself, at least this second Daria Hazuda, scientific director of MSD, Merck's label operating outside the US.

molnupiravir
The doctor Daria Hazuda, scientific director of the Merck brand license holder on Molnupiravir

The study produced the most effective result ever in an orally available drug in treating a respiratory pathogen. The ability to get an oral pill that can inhibit viral replication, which can inhibit this virus, will be a real game changer.

Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, in a statement on Molnupiravir.

Merck says it "will seek emergency use authorization in the United States as soon as possible" as well as its plans to submit applications to other regulatory agencies around the world.

If licensed, this Molnupiravir pill could be the first oral antiviral drug formulated to fight COVID-19.

Tags: Coronavirusmerck

Latest news

  • EV, goodbye frequent charging: I-State promises over 1.000 km of autonomy.
  • Revolutionary generator transforms humidity into continuous electrical energy
  • All the maps of the future: from research tools to doors to tomorrow
  • The bizarre AI that translates the language of chickens
  • Jeddah Tower, construction site of the one kilometer high skyscraper reopens
  • Spider silk from modified silkworms: stronger than Kevlar and 100% natural
  • VIR-1388, HIV vaccine being tested in the USA and South Africa
  • MOWT, innovative floating hydroelectric for slow-flowing waters
  • CRAFT, what stage is the Chinese project to build an artificial Sun?
  • Remote work, halved emissions


GPT Chat Megaeasy!

Concrete guide for those approaching this artificial intelligence tool, also designed for the school world: many examples of applications, usage indications and ready-to-use instructions for training and interrogating Chat GPT.

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Transports
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Read more
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP
  • Privacy Policy

© 2023 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Transports
  • Spazio
  • AI
  • concepts
  • H+